Access cutting-edge fabry disease treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.
Access fabry disease specialists in Cleveland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related fabry disease treatment provided free
An Open-label Study to Evaluate the Safety and Pharmacokinetics of Migalastat HCl in Subjects with Fabry Disease and Amenable GLA Variants and Severe Renal Impairment (SRI) or End Stage Renal Disease (ESRD)
Sponsor: Amicus Therapeutics
Check if you qualify for this fabry disease clinical trial in Cleveland, OH
If you're searching for fabry disease treatment options in Cleveland, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced fabry disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.